PROTEINA CO.,LTD.

468530KOSDAQResearch and development

PROTEINA CO.,LTD. (468530, KOSDAQ) reported KRW 3bn revenue in 2025.

Broker research: target prices and ratings

2 reports from 2 firms between 2026-09-28 and 2026-10-08. None of these reports stated a target price.

Newest first. Ratings are as each firm stated them, translated into English. "Not stated" means the report carried no value — it is not a zero.

DateTarget priceRatingFirmAnalyst
Not statedNot statediM SecuritiesNot stated
Not statedNot statedKorea IR ServiceNot stated

Some publishers here are not securities firms — credit-information agencies and the Korea IR Service publish company analysis but do not issue target prices.

Report titles are not shown: the source lists them in Korean only, and we do not publish our own translation of another firm's headline.

This is a record of what brokers published, not investment advice. It is a sample of broker research — the reports our collection picked up, not every report written on this company — and the range and median describe that sample, not a market consensus. These are statistics, not a verdict.

Source: broker reports collected by SeoulMarkets from Naver Finance's research listing and from brokers' own websites, 2026-06-29 to 2026-10-28.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
2021——————
2022——————
2023——————
2024——————
20253-11-93228Separate

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
2021————
2022————
2023————
2024————
2025-385.2%-305.4%89.4%-31.8%

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 324bn
Close priceKRW 29,200
Listed shares11,105,148
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

When it was founded

The incorporation date on the company's registration record, as filed with Korea's Financial Supervisory Service. This is when the company was legally formed — not when it first listed, and not when the business it grew out of began trading.

Incorporated

Who runs it

Registered representative directors — in Korea this is the office a CEO holds. Filed with the Financial Supervisory Service (DART). A Korean company can register more than one, and the title beside each name is the rank they carry inside the company.

NameTitleBoard seatYears in post
Yoon Tae-yeong (윤태영)Representative Director (CEO)Inside director5 years

Roman spellings are ours, converted from the Korean filing. The person may spell their own name differently in English. The Korean name in brackets is what was filed.

Workforce — a side measure, not the main one

Employees (2025)53
Women25 (47.2%)
Average tenure2.3 years
Annual pay, menKRW 79,365,000
Annual pay, womenKRW 59,510,000
Pay ratio, women to men75%

Other companies in Research and development

63 listed companies file under this classification. Showing 12.

See the whole Research and development list →